Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/1995
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446022 Cyclic polypeptides; protozoicides and fungicides;
08/29/1995US5445938 Screening for presence of cancer cells in large bowel tissue sample
08/29/1995US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use
08/29/1995CA1336826C Chimeric antibody with specificity to human b cell surface antigen
08/24/1995WO1995022625A1 Dna mutagenesis by random fragmentation and reassembly
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022614A1 Production of glycosylphosphatidylinositol-anchored recombinant proteins
08/24/1995WO1995022613A1 Tumor associated monoclonal antibody 123av16
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
08/24/1995WO1995022604A1 Rna editing enzyme and methods of use thereof
08/24/1995WO1995022563A1 Antigenic preparation for treatment or prevention of helicobacter infection
08/24/1995WO1995022389A1 Antibody purification
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183253A1 Rna editing enzyme and methods of use thereof
08/24/1995CA2181827A1 Cyclic heptapeptide anti-inflammatory agent
08/23/1995EP0668357A1 Vector for integration site independent gene expression in mammalian host cells
08/23/1995EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0668292A2 Process to obtain insulin with correct cystin bridges
08/23/1995EP0667959A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE $g(b)-AMYLOID PEPTIDE
08/23/1995EP0667917A1 Evolutive vaccination.
08/23/1995EP0667916A1 Crf binding protein
08/23/1995EP0667915A1 Protease-stable proteins
08/23/1995EP0667910A1 A bacillus promoter derived from a variant of a bacillus licheniformis x-amylase promoter
08/23/1995EP0667909A1 Biotechnological method of producing biotin
08/23/1995EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer
08/23/1995EP0667898A1 Tau/neurofilament protein kinases pk40 and pk36
08/23/1995EP0667896A1 Direct selection of cells by secretion product
08/23/1995EP0667872A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
08/23/1995EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/22/1995US5444164 TGF-β induced gene
08/22/1995US5444159 Purification of a pertussis outer membrane protein
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444155 Molecules with antibody combining sites that induce asymmetry
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444151 Platelet derived growth factor antagonists
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5443969 In vivo system for expression and packaging a genetic engineered single stranded RNA of unlimited length into pseudovirus particles comprised of plant viral coat proteins; storage stability, ribonuclease resistant
08/22/1995US5443968 Fed batch culture method for protein secreting cells
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443966 Expression of tetanus toxin fragment C
08/22/1995US5443965 Peptide antigens used in diagnosis
08/22/1995US5443957 Cancer diagnosis
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443828 AIDS vaccine
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/22/1995CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
08/22/1995CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
08/17/1995WO1995021938A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
08/17/1995WO1995021928A1 Process for the production of a heterologous protein from a methylotrophic yeast
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021925A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
08/17/1995WO1995021923A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
08/17/1995WO1995021921A1 Mammalian thymokine genes
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995WO1995021860A1 Methods for variation of chromatin condensation
08/17/1995WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2183166A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182967A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182574A1 Mammalian thymokine genes
1 ... 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 ... 1125